Jump to main content
Jump to site search

Issue 11, 2011
Previous Article Next Article

Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

Author affiliations

Abstract

Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.

Graphical abstract: Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Dec 2010, accepted on 11 Jan 2011 and first published on 26 Jan 2011


Article type: Communication
DOI: 10.1039/C0CC05428C
Chem. Commun., 2011,47, 3144-3146

  •   Request permissions

    Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

    J. Martinelli, M. Fekete, L. Tei and M. Botta, Chem. Commun., 2011, 47, 3144
    DOI: 10.1039/C0CC05428C

Search articles by author

Spotlight

Advertisements